WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006

Feb 28, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-02-24	Common Stock	A	25381	—	Acquired	227220.1178	Direct
2006-02-24	Common Stock	A	4698.4932	$32.5850	Acquired	231918.6110	Direct
2006-02-24	Common Stock	A	9000	—	Acquired	240918.6110	Direct
2006-02-24	Common Stock	A	28.62	$25.2000	Acquired	12663.2889	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-02-24	Stock Option (Right to Buy)	$32.5850	A	74257	Acquired	2016-02-24	Common Stock (74257.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	771.1149	Indirect

Footnotes

F1: Bonus and incentive shares granted on 2/24/06.

F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.

F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.